Iron lead Iron Historically iron was a common cause of childhood poisoning deaths The severity of an exposure is related to the amount of elemental iron ingested Ferrous sulfate contains 20 elemental iron ferrous gluconate 12 and ferrous fumarate 33 ID: 920904
Download Presentation The PPT/PDF document "Poisoning Continue on selected drug po..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Poisoning
Continue on selected drug poisoning
Iron
lead
Slide2Iron
Historically, iron was a common cause of childhood poisoning deaths. The severity of an exposure is related to the amount of
elemental iron
ingested. Ferrous sulfate contains 20% elemental iron, ferrous gluconate 12%, and ferrous fumarate 33
%.
Slide3Pathophysiology
Iron is directly corrosive to the GI mucosa, leading to hematemesis, melena, ulceration, infarction, and potential perforation.
Early iron-induced hypotension
is due to massive volume losses, increased permeability of capillary membranes, and
venodilation
mediated by free iron.
Iron accumulates in tissues, including the
Kupffer
cells of the liver and myocardial cells, leading to hepatotoxicity, coagulopathy, and cardiac dysfunction
Slide4Pediatric patients who ingest >40 mg/kg of elemental iron should be referred to medical care for evaluation, though moderate to severe toxicity is typically seen with ingestions of >60 mg/kg.
Clinical and Laboratory Manifestations:
Iron toxicity is classically described in 4, often overlapping, stages
The initial stage
, 30 min to 6 hr after ingestion, consists of profuse vomiting and diarrhea (often bloody), abdominal pain, and significant volume losses leading to potential
hypovolemic
shock.
The second stage, 6 to 24 hr
after ingestion, is the quiescent phase, as GI symptoms typically resolve. careful clinical exam can reveal subtle signs of
hypoperfusion
, including tachycardia, pallor, and fatigue
Slide6During the third stage, occurring 12 to 24 hr after ingestion, patients develop multisystem organ failure, shock, hepatic and cardiac
dysfunction.
the
fourth stage
(4 to 6 wk after ingestion) is marked by formation of strictures and signs of GI obstruction.
Symptomatic patients and patients with a large exposure by history should have serum iron levels drawn 4-6 hr after ingestion.
Other lab.
Invstigations
….
blood gas, complete blood count, serum glucose level, liver function tests, and coagulation parameters
An abdominal x-ray might reveal the presence of iron tablets.
Slide7Treatment Close clinical monitoring, combined with aggressive supportive and symptomatic care, is essential to the management of iron poisoning.
Activated charcoal does not adsorb iron, and WBI remains the decontamination strategy of choice.
Deferoxamine, a specific
chelator
of iron, is the antidote for moderate to severe iron intoxication.
Indications for deferoxamine treatment
include a serum iron concentration of >500 mg/
dL
or moderate to severe symptoms of toxicity, regardless of serum iron concentration.
Slide8Deferoxamine is preferably given via continuous IV infusion at a rate of 15 mg/kg/hr.
Hypotension is a common side effect of
deferoxamine
infusion. Prolonged
deferoxamine infusion (>24 hr) has been associated with pulmonary toxicity (acute respiratory distress syndrome) and
Yersinia
sepsis.
The deferoxamine-iron complex can color the urine reddish (“
vin
ros
?”), though this is an unreliable indicator of iron excretion, therapy is typically continued until clinical symptoms resolve.
Slide9Lead Poisoning
Lead is a metal that exists in four isotopic forms. Clinically, it is purely a toxicant; no organism has an essential function that is lead-dependent.. The blood lead level (BLL) is the gold standard for determining health effects.
BLL of
5
microg
/
dL
???
or greater regarded as a level of concern for public health purposes.
Slide10Sources of Exposure
Several hundred products contain lead, including batteries, cable sheathing, cosmetics, mineral supplements, plastics,
toys,lead
-based paint. As paint deteriorates, it chalks, flakes, and turns to dust .The dust can coat all surfaces, including children's hands. All of these forms of lead can be ingested.
Slide11SOURCES OF LEADPaint chips
Dust
Soil
Parent's or older child's occupational exposure
(painting
)
Home
remedies, including antiperspirants
Stored battery casings (or living near a battery smelter)
Lead-based gasoline
Lead-based
cosmetics (kohl)
Imported
foods in lead-containing cans
Imported toys
Home renovations
Antique toys or furniture
Slide12Metabolism
The nonnutritive hand-to-mouth activity of young children is the most common pathway by which lead enters the body. In nearly all cases, lead is ingested.
After absorption, lead is disseminated throughout the body. Most retained lead accumulates in bone, where it may reside for years. It circulates bound to erythrocytes; about 97% in blood is bound on or in the red blood
cells.
Slide13Lead has multiple effects in cells………
It binds to enzymes
, particularly those with available
sulfhydryl
groups, changing the contour and diminishing function.
The
heme
pathway, present in all cells, has three enzymes susceptible to lead inhibitory effects.
The last enzyme in this pathway,
ferrochelatase
, enables
protoporphyrin
to
chelate
iron, thus forming
heme
.
Protoporphyrin
is readily measurable in red blood cells. Levels of
protoporphyrin
higher than 35
microg
/
dL
are abnormal and are consistent with lead poisoning, iron deficiency, or recent inflammatory disease.
A second mechanism of lead toxicity works via its competition with calcium. Many calcium-binding proteins have a higher affinity for lead than for
calcium.
a third mechanism
prevents the development of the normal tertiary brain structure.
Clinical
Effects
The BLL is the best-studied measure of the lead burden in children.
Slide15Hearing and height are inversely related to BLLs in children;. Children with higher BLLs are slightly shorter than those with lower levels; for every 10
microg
increase in the BLL, the children are 1 cm shorter. Chronic lead exposure also may delay puberty.
there is agreement that
BLLs are
inversely related to cognitive test scores. Because the BLLs from early childhood are predictors of the cognitive test results performed years later, this finding implies that the effects of lead can be permanent.
Slide16The effect of in utero lead exposure is less clear maternal blood lead levels between 0 and 10microg/
dL
even as early as the first trimester were associated with about a 6-point drop in cognitive test score results when the children were tested up to age 10 yr.
Behavior also is adversely affected by lead exposure. Hyperactivity is noted in young school-aged children with histories of lead poisoning or with concurrent elevations in BLL.
Slide17Clinical Symptoms
Gastrointestinal Tract and Central Nervous System
GI symptoms
of lead poisoning include anorexia, abdominal pain, vomiting, and constipation, often occurring and recurring over a period of weeks.
CNS symptoms
are related to worsening cerebral edema and increased intracranial pressure. Headaches, change in mentation, lethargy, papilledema, seizures, and coma leading to death are rarely seen at levels lower than 100
microg
/
dL
but have been reported in children with a BLL as low as 70
microg
/
dL
.
Slide18At high levels (>100 microg/
dL
),
renal tubular dysfunction
is observed. Lead may induce a reversible
Fanconi
syndrome.
at high BLLs,
red blood cell survival
is shortened, possibly contributing to a hemolytic anemia, although most cases of anemia in lead-poisoned children are due to other factors, such as iron deficiency and
hemoglobinopathies
.
Older patients may develop a
peripheral neuropathy.
Slide19Diagnosis
Screening
It is estimated that 99% of lead-poisoned children are identified by screening procedures rather than through clinical recognition of lead-related
symptoms
In general, it is advisable to screen high-risk children, including those with the following characteristics:
1.Having a sibling or playmate with an elevated lead level
2.Living with an adult whose job or hobby involves lead
3.Living near an industry that is likely to release lead (e.g., smelting plant, battery-recycling plant
4. the child is a recent immigrant from a country that still permits use of leaded gasoline
5.or the child has pica or developmental delay
Slide20NOT RECOMMENDED AT ANY BLOOD LEAD CONCENTRATIONSearching for gingival lead linesEvaluation of renal function (except during chelation with CaNa
2
EDTA [
ethylenediaminetetraacetic
acid])
Testing of hair, teeth, or fingernails for lead
Radiographic imaging of long bones
X-ray fluorescence of long bones
Slide21Other Tools for Assessment BLL determinations remain the gold standard for evaluating children.
Experimentally, the method of
x-ray fluorescence (XRF) allows direct and noninvasive assessment of bone lead stores.
the
lead mobilization test
.
Lead in hair also is measurable but has problems of contamination and interpretability.
Radiographs of long bones
may show dense bands at the
metaphyses
.
Slide22For children with acute symptoms,, a kidneys-ureters-bladder (
KUB) radiograph may reveal
radiopaque
flecks
in the intestinal tract, a finding that is consistent with recent ingestion of lead-containing plaster or paint chips.
An
elevated EP value
that cannot be attributed to iron deficiency or recent inflammatory illness
is both an indicator of lead effect and a useful means of assessing the success of the treatment
.
Slide23Treatment Once lead is in bone, it is released only slowly and is difficult to remove even with chelating agents. Because the cognitive/behavioral effects of lead may be irreversible,
the main effort in treating lead poisoning
is to
prevent
it from occurring and to
prevent
further ingestion by already-poisoned children.
(
1) identification and elimination of environmental sources of lead exposure,
(2) behavioral modification to reduce nonnutritive hand-to-mouth activity, and
(3) dietary counseling to ensure sufficient intake of the essential elements calcium and iron.
Slide24(4)For the small minority of children with more severe lead poisoning, drug treatment is available that enhances lead excretion.Parental efforts at
reducing the hand-to-mouth activity
of the affected child are necessary to reduce the risk of lead ingestion,
handwashing
is best limited to the period immediately before nutritive hand-to-mouth activity occurs.
Because there is competition between lead and essential minerals, it is reasonable to promote a healthy diet that is sufficient in calcium and iron.
In general, for children 1 yr of age and up a calcium intake of about 1 g per day is sufficient
Slide25Iron requirements also vary with age, ranging from 6 mg/day for infants to 12 mg/day for adolescents.
Drug treatment
to remove lead is lifesaving for children with lead encephalopathy. In
nonencephalopathic
children, it prevents symptom progression and further toxicity.
Four drugs are available :
2,3-dimercaptosuccinic acid (DMSA [
succimer
])
CaNa
2
EDTA (
versenate
)
penicillamine
British
antilewisite
(BAL [
dimercaprol
]),
DMSA and
penicillamine
can be given orally, whereas CaNa
2
EDTA and BAL can be administered only
parenterally
.
<25 μ
g/
dL
Chelation is not indicated.
25-45 μ
g/
dL
Chelation is not routinely indicated because no evidence exists that chelation prevents or reverses neurotoxicity. Some patients may benefit from (oral) chelation (e.g.,
succimer
), especially if elevated levels persist despite aggressive environmental intervention and abatement
45-70 μ
g/
dL
Chelation is indicated with either
succimer
or CaNa
2
EDTA (if no clinical symptoms suggestive of encephalopathy are present [e.g., headache, persistent vomiting]). If symptoms of encephalopathy are seen, chelation With
dimercaprol
and CaNa
2
EDTA are indicated. Before chelation, an abdominal radiograph scan should be taken to evaluate for the possible removable of
enteral
lead.
>70 μ
g/
dL
Inpatient chelation therapy with
dimercaprol
and CaNa
2
EDTA is indicated.
Slide27NAME
SYNONYM
DOSE
TOXICITY
Succimer
Chemet
, 2,3-dimercaptosuccinic acid (DMSA)
350 mg/m
2
body surface area/dose (
not 10 mg/kg
) q8h, PO for 5 days, then q12h for 14 days
Gastrointestinal distress, rashes; elevated LFTs, depressed white blood cell count
Edetate
CaNa
2
EDTA (calcium disodium edetate), versenate
1,000-1,500 mg/m
2
body surface area/d; IV infusion—continuous or intermittent; IM divided q6h or q12h for 5 days
Proteinuria
,
pyuria
, rising blood urea nitrogen/
creatinine
—all rare
Hypercalcemia
if too rapid an infusion
Tissue inflammation if infusion infiltrates
Slide28British
antilewisite
(BAL)
Dimercaprol, British antilewisite
300-500 mg/m
2
body surface area/ day;
IM only
divided q4h for 3-5 days. Only for BLL ≥ 70 ?g/dL
GI distress, altered
mentation
; elevated LFTs, hemolysis if glucose-6-phosphate
dehydrogenase
deficiency; no concomitant iron treatment
D-Pen
Penicillamine
10 mg/kg/d for 2 wk increasing to 25-40 mg/kg/d; oral, divided q12h.
For 12-20 wk
Rashes, fever; blood
dyscrasias
, elevated LFTs,
proteinuria
Allergic cross-reactivity with penicillin
Slide29All of the drugs are effective in reducing BLLs when given in sufficient doses and for the prescribed time. These drugs also may increase lead absorption from the gut and should be administered to children in lead-free environments.
None of these agents removes all lead from the body. Within days to weeks after completion of a course of therapy the BLL rises, even in the absence of new lead ingestion. The source of this rebound in the BLL is believed to be bone.
With successful intervention, BLLs decline, with the greatest fall in BLL occurring in the first 2 mo after therapy is initiated. Subsequently the rate of change in BLL declines slowly so that by 6-12 mo after identification, the BLL of the average child with moderate lead poisoning (BLL >20
microg
/
dL
) will be 50% lower.
Slide30Early screening remains the best way of avoiding and therefore obviating the need for the treatment of lead poisoning.